|
Simulation Plus, Inc. (SLP) Valoración de DCF
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Simulations Plus, Inc. (SLP) Bundle
¡Mejore sus opciones de inversión con la calculadora DCF (SLP)! Explore simulaciones auténticas más datos financieros, ajuste las estimaciones y gastos de crecimiento, y observe instantáneamente cómo las modificaciones influyen en el valor intrínseco de (SLP).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.6 | 46.5 | 53.9 | 59.6 | 70.0 | 79.8 | 90.9 | 103.6 | 118.0 | 134.5 |
| Revenue Growth, % | 0 | 11.73 | 16.01 | 10.52 | 17.52 | 13.94 | 13.94 | 13.94 | 13.94 | 13.94 |
| EBITDA | 11.9 | 14.7 | 18.5 | 12.6 | 11.8 | 21.1 | 24.1 | 27.4 | 31.2 | 35.6 |
| EBITDA, % | 28.5 | 31.63 | 34.29 | 21.09 | 16.85 | 26.47 | 26.47 | 26.47 | 26.47 | 26.47 |
| Depreciation | 3.0 | 3.6 | 3.6 | 3.8 | 5.7 | 5.7 | 6.5 | 7.5 | 8.5 | 9.7 |
| Depreciation, % | 7.12 | 7.73 | 6.63 | 6.45 | 8.09 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 |
| EBIT | 8.9 | 11.1 | 14.9 | 8.7 | 6.1 | 15.4 | 17.5 | 20.0 | 22.7 | 25.9 |
| EBIT, % | 21.38 | 23.9 | 27.66 | 14.64 | 8.76 | 19.27 | 19.27 | 19.27 | 19.27 | 19.27 |
| Total Cash | 116.0 | 123.6 | 128.2 | 115.5 | 20.3 | 68.4 | 78.0 | 88.9 | 101.2 | 115.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 10.5 | 13.1 | 13.8 | 10.2 | 9.1 | 17.4 | 19.8 | 22.6 | 25.8 | 29.3 |
| Account Receivables, % | 25.28 | 28.09 | 25.58 | 17.12 | 13.05 | 21.82 | 21.82 | 21.82 | 21.82 | 21.82 |
| Inventories | 1.0 | 1.0 | 1.4 | .8 | .0 | 1.3 | 1.5 | 1.7 | 2.0 | 2.3 |
| Inventories, % | 2.33 | 2.18 | 2.58 | 1.35 | 0 | 1.69 | 1.69 | 1.69 | 1.69 | 1.69 |
| Accounts Payable | .4 | .4 | .2 | .1 | .6 | .5 | .6 | .7 | .8 | .9 |
| Accounts Payable, % | 0.84397 | 0.83287 | 0.41739 | 0.2417 | 0.85984 | 0.63916 | 0.63916 | 0.63916 | 0.63916 | 0.63916 |
| Capital Expenditure | -2.6 | -4.6 | -4.0 | -4.3 | -.6 | -5.0 | -5.7 | -6.5 | -7.4 | -8.4 |
| Capital Expenditure, % | -6.21 | -9.85 | -7.36 | -7.17 | -0.80842 | -6.28 | -6.28 | -6.28 | -6.28 | -6.28 |
| Tax Rate, % | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 |
| EBITAT | 7.3 | 9.8 | 12.3 | 7.4 | 4.9 | 12.9 | 14.6 | 16.7 | 19.0 | 21.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.5 | 6.3 | 10.6 | 11.1 | 12.3 | 3.9 | 12.9 | 14.7 | 16.8 | 19.1 |
| WACC, % | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 | 7.79 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 52.1 | |||||||||
| Long Term Growth Rate, % | 3.90 | |||||||||
| Free cash flow (T + 1) | 20 | |||||||||
| Terminal Value | 511 | |||||||||
| Present Terminal Value | 351 | |||||||||
| Enterprise Value | 404 | |||||||||
| Net Debt | -9 | |||||||||
| Equity Value | 413 | |||||||||
| Diluted Shares Outstanding, MM | 20 | |||||||||
| Equity Value Per Share | 20.34 |
What You Will Get
- Real SLP Financial Data: Pre-filled with Simulations Plus’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Simulations Plus’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Simulations Plus, Inc. (SLP).
- Adjustable Forecast Parameters: Modify highlighted cells to tailor WACC, growth rates, and margins to your needs.
- Real-Time Calculations: Experience automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: Utilize user-friendly charts and summaries to effectively visualize your valuation outcomes.
- Suitable for All Skill Levels: Designed with a straightforward, intuitive layout for investors, CFOs, and consultants alike.
How It Works
- 1. Access the Model: Download and open the Excel file containing Simulations Plus, Inc. (SLP) preloaded data.
- 2. Adjust Parameters: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
- 5. Present with Assurance: Deliver professional valuation insights that enhance your decision-making process.
Why Choose Simulations Plus, Inc. (SLP)?
- Streamlined Processes: Get instant access to powerful simulation tools without the hassle of setup.
- Enhanced Precision: Utilize cutting-edge algorithms and data to minimize errors in drug development.
- Highly Adaptable: Customize simulations to align with your specific research needs and goals.
- User-Friendly Interface: Intuitive design and visual outputs facilitate straightforward analysis.
- Respected by Industry Leaders: Trusted by pharmaceutical experts who prioritize accuracy and effectiveness.
Who Should Use Simulations Plus, Inc. (SLP)?
- Pharmaceutical Researchers: Utilize advanced simulation tools to model drug interactions and outcomes.
- Academic Institutions: Enhance curriculum with state-of-the-art pharmacokinetic and pharmacodynamic models.
- Regulatory Agencies: Assess drug efficacy and safety through robust simulations before clinical trials.
- Biotech Companies: Optimize drug development processes with customizable simulation software.
- Healthcare Professionals: Understand and predict patient responses to treatments using simulation data.
What the Template Contains
- Pre-Filled DCF Model: Simulations Plus, Inc.’s (SLP) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Simulations Plus, Inc.’s (SLP) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.